Science Signaling · 2020 · 40 citations · 42 references
MedicineCancer BiologyOncologyCell SignalingMolecular OncologySignal TransductionBladder CancerCancer Cell SignalingCancer ProgressionOncogenic Signaling PathwaysSignal Transduction In CancerUrothelial CarcinomaAntioxidant Defense GenesCancer Signaling PathwaysCell Proliferation SignalingMuscle-invasive Bladder Cancer TherapyNrf2 Pathway ActivationNrf2 Signaling PathwayPlatinum CompoundsTumor Cell Proliferation
was observed in most cisplatin nonresponder cases. Silencing of GULP1 was associated with GULP1 promoter hypermethylation in cell lines and primary tumors, and a high frequency of GULP1 promoter methylation was observed in multiple sets of primary clinical UCB samples. Together, our findings demonstrate that GULP1 is a KEAP1-binding protein that regulates KEAP1-NRF2 signaling in UCB and that promoter hypermethylation of GULP1 is a potential mechanism of GULP1 silencing.
42
Primer3 on the WWW for General Users and for Biologist Programmers
Steve Rozen, Helen Skaletsky · Humana Press eBooks · 2003 · 15.1K citations
Dysfunctional KEAP1–NRF2 Interaction in Non-Small-Cell Lung Cancer
Anju Singh, Vikas Misra, Rajesh K. Thimmulappa et al. · PLoS Medicine · 2006 · 1K citations · Full text
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
X.-J. Wang, Zheng Sun, Nicole Villeneuve et al. · Carcinogenesis · 2008 · 842 citations · Full text